XRHealth launches VR/AR platform to connect doctors with patients

XRHealth has developed a new platform that allows physicians and their patients to communicate directly using virtual reality (VR) and augmented reality (AR). Patients use the network to control who has access to their data. Once granted access, healthcare providers can continuously monitor the patient and make treatment decisions as needed.

The company launched its new network during the Qualcomm Snapdragon Tech Summit 2019 in Maui, Hawaii.

“With the roll out of 5G throughout the globe, the new technology implications for the telehealth industry are enormous,” Eran Orr, CEO of XRHealth, said in a prepared statement. “Patients will be able to use high bandwidth technology like VR or AR anywhere they are located—whether in a rural or urban area. Healthcare will become much more affordable and accessible to anyone while innovation will be endless.”

“In Maui, we are excited to showcase the telehealth platform for the first time to demonstrate the vast potential of XR as a way to accelerate overall wellness and health while transforming how hospitals and healthcare facilities enrich the lives of physicians and patients,” Brian Vogelsang, senior director of product management for QualComm Technologies, said in the same statement.

Back in November, XRHealth and Sheba Medical Center (SMC) in Israel announced a new collaboration to make SMC the world’s first fully VR-based hospital.

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Around the web

CMS finalized a significant policy change when it increased the Medicare payments hospitals receive for performing CCTA exams. What, exactly, does the update mean for cardiologists, billing specialists and other hospital employees?

Stryker, a global medtech company based out of Michigan, has kicked off 2025 with a bit of excitement. The company says Inari’s peripheral vascular portfolio is highly complementary to its own neurovascular portfolio.

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.